Biotech Turnaround Fund (BTF)
Europe, Noord-Holland, The Netherlands, Bloemendaal
Description
Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six
Investor Profile
Biotech Turnaround Fund (BTF) has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series D, Series E rounds (top funding stages).
- Majority of deals are located in Canada, United States.
- Strong thematic focus on Biotechnology, Genetics, Life Science.
Stage Focus
- Series Unknown (43%)
- Series D (29%)
- Series E (14%)
- Series A (14%)
Country Focus
- Canada (71%)
- United States (29%)
Industry Focus
- Biotechnology
- Genetics
- Life Science
- Medical Device
- Pharmaceutical
- Biopharma
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Biotech Turnaround Fund (BTF) frequently co-invest with?
What are some of recent deals done by Biotech Turnaround Fund (BTF)?
Find More Investors Like Biotech Turnaround Fund (BTF)
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
